Omeros Corporation
0.37 (11.38%)
Company Name Stock Ticker Symbol Market Type
Omeros Corporation OMER NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.37 11.38% 3.62 14:10:30
Open Price Low Price High Price Close Price Prev Close
3.26 3.25 3.63 3.25
more quote information »

Recent News

Date Time Source Heading
3/21/20237:56IHNWFeaturedPredictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening
3/13/202316:02BWOmeros Corporation Reports Fourth Quarter and Year-End 2022..
3/10/202315:37BWOmeros Corporation Confirms Absence of Financial Exposure to..
3/07/202309:00BWOmeros Corporation to Announce Fourth Quarter and Year End..
2/14/202316:32EDGARAmended Statement of Ownership (sc 13g/a)
2/09/202311:42EDGARAmended Statement of Ownership (sc 13g/a)
2/06/202309:01EDGARCurrent Report Filing (8-k)
2/06/202308:50BWOmeros Corporation Receives $200 Million Milestone Payment..
11/18/202206:04EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/16/202215:25TRMNMaxim Group Keeps Their Hold Rating on Omeros (OMER)
11/10/202206:25TRMNNeedham Reaffirms Their Hold Rating on Omeros (OMER)
11/09/202216:07EDGARCurrent Report Filing (8-k)
11/09/202216:02BWOmeros Corporation Reports Third Quarter 2022 Financial..
11/08/202208:30BWOmeros Corporation Receives Decision from FDA on Formal..
11/04/202209:00BWOmeros Corporation to Announce Third Quarter Financial..
11/03/202209:00BWOmeros Corporation Announces Upcoming Presentations at ASH..
10/06/202216:43EDGARCurrent Report Filing (8-k)
10/03/202207:10BWOmeros Corporation Announces Royalty Monetization..
9/15/202210:39TRMNOmeros (NASDAQ:OMER) Tanks on COVID-19 Therapy Data
9/15/202209:06BWOmeros Corporation Reports Narsoplimab Treatment Results in..
9/15/202209:02BWI-SPY COVID Trial Sponsored by Quantum Leap Healthcare..
8/17/202208:40BWOmeros Corporation Receives Interim Response from FDA on..
8/13/202212:05TRMNMaxim Group Keeps Their Hold Rating on Omeros (OMER)
8/09/202216:20EDGARQuarterly Report (10-q)
8/09/202216:12EDGARCurrent Report Filing (8-k)
8/09/202216:02BWOmeros Corporation Reports Second Quarter 2022 Financial..
8/04/202208:30BWOmeros Corporation to Announce Second Quarter Financial..
7/29/202209:25DJNOmeros Gets FDA Orphan-Drug Designation for OMS906 in PNH
7/29/202208:45BWFDA Grants Orphan Drug Designation to Omeros’ MASP-3..
7/08/202216:59EDGARStatement of Ownership (sc 13g)
6/22/202217:25EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202217:25EDGARStatement of Changes in Beneficial Ownership (4)
6/15/202208:00BWOmeros Announces Webcast Details for Annual Meeting of..
5/11/202210:55TRMNNeedham Sticks to Its Hold Rating for Omeros (OMER)
5/11/202206:08EDGARNotice of Effectiveness (effect)
5/10/202216:20EDGARCurrent Report Filing (8-k)
5/10/202216:02BWOmeros Corporation Reports First Quarter 2022 Financial..
5/04/202208:30BWOmeros Corporation to Announce First Quarter Financial..
5/03/202216:15TRMNNeedham Maintains a Hold Rating on Omeros (OMER)
4/20/202208:45BWOmeros Announces Journal of Clinical Oncology Publication..
4/10/202223:00QUIVRNew Corporate Lobbying data: $OMER recently disclosed $80..